Loading...
RxSight, Inc.
RXST•NASDAQ
Healthcare
Medical - Devices
$7.97
$0.03(0.38%)
RxSight, Inc. (RXST) Financial Performance & Income Statement Overview
Review RxSight, Inc.’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
Revenue Growth
57.09%
↑ 57.09%
Operating Income Growth
26.41%
↑ 26.41%
Net Income Growth
43.52%
↑ 43.52%
Operating Cash Flow Growth
59.26%
↑ 59.26%
Operating Margin
-23.27%
↓ 23.27%
Gross Margin
67.29%
↑ 67.29%
Net Profit Margin
-16.76%
↓ 16.76%
ROE
-9.54%
↓ 9.54%
ROIC
-12.70%
↓ 12.70%
RxSight, Inc. (RXST) Income Statement & Financial Overview
Review RxSight, Inc.'s (RXST) income statement with detailed quarterly and annual figures.
| Metric | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|
| Revenue | $40.21M | $45.41M | $34.89M | $29.51M |
| Cost of Revenue | $11.43M | $20.19M | $10.64M | $8.83M |
| Gross Profit | $28.79M | $25.22M | $24.25M | $20.68M |
| Gross Profit Ratio | $0.72 | $0.56 | $0.70 | $0.70 |
| R&D Expenses | $9.21M | $8.84M | $8.29M | $8.03M |
| SG&A Expenses | $28.21M | $25.61M | $24.29M | $23.32M |
| Operating Expenses | $37.42M | $34.45M | $32.58M | $31.36M |
| Total Costs & Expenses | $48.84M | $54.63M | $43.22M | $40.18M |
| Interest Income | $2.71M | $2.91M | $2.28M | $1.58M |
| Interest Expense | $5000.00 | $5000.00 | $6000.00 | $6000.00 |
| Depreciation & Amortization | $523000.00 | $1.14M | $820000.00 | $1.14M |
| EBITDA | -$5.40M | -$5.18M | -$5.24M | -$7.95M |
| EBITDA Ratio | -$0.13 | -$0.11 | -$0.15 | -$0.27 |
| Operating Income | -$8.63M | -$9.23M | -$8.33M | -$10.67M |
| Operating Income Ratio | -$0.21 | -$0.20 | -$0.24 | -$0.36 |
| Other Income/Expenses (Net) | $2.70M | $2.90M | $2.27M | $1.58M |
| Income Before Tax | -$5.93M | -$6.33M | -$6.06M | -$9.09M |
| Income Before Tax Ratio | -$0.15 | -$0.14 | -$0.17 | -$0.31 |
| Income Tax Expense | $12000.00 | $13000.00 | $16000.00 | $9000.00 |
| Net Income | -$5.94M | -$6.34M | -$6.08M | -$9.10M |
| Net Income Ratio | -$0.15 | -$0.14 | -$0.17 | -$0.31 |
| EPS | -$0.15 | -$0.16 | -$0.16 | -$0.25 |
| Diluted EPS | -$0.15 | -$0.16 | -$0.16 | -$0.25 |
| Weighted Avg Shares Outstanding | $40.36M | $39.79M | $38.46M | $36.84M |
| Weighted Avg Shares Outstanding (Diluted) | $40.36M | $39.79M | $38.46M | $36.84M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan